生物
弥漫性大B细胞淋巴瘤
原发性中枢神经系统淋巴瘤
外显子组测序
淋巴瘤
癌症研究
转录组
中枢神经系统
免疫系统
免疫学
基因
突变
遗传学
基因表达
神经科学
作者
Zonghua Wang,Hong Chen,Bo Dai,Kang H. Zheng,Jiajun Zheng,Yuqi Zhu,Yan Yuan,Tianling Ding,Qian Wang,Liqian Xie,Rui Feng,Fengping Zhu,Jingyuan Xiang,Wei‐Qun Ding,Hong Ding,Yuan Li,Xiaodong Gu,Kunpeng Wu,Yifan Yuan,Jianping Song
出处
期刊:Neoplasia
[Elsevier BV]
日期:2024-12-28
卷期号:60: 101119-101119
被引量:2
标识
DOI:10.1016/j.neo.2024.101119
摘要
Primary central nervous system diffused large B-cell lymphoma (PCNS-DLBCL) is a rare type of non-Hodgkin lymphoma restricted to the central nervous system (CNS). To explore its specific pathogenesis and therapeutic targets, we performed multi-omics sequencing on tumor samples from patients diagnosed with PCNS-DLBCL, secondary CNS-DLBCL or extracranial (ec) DLBCL.By single-cell RNA sequencing, highly proliferated and dark zone (DZ)-related B cell subclusters, MKI67_B1, PTTG1_B2 and BTG1_B3, were predominant significantly in PCNS-DLBCL. Compared to SCNS-DLBCL and ecDLBCL, an immune-suppressive tumor microenvironment was observed in PCNS-DLBCL by analysis of immune-stimulating/inhibitory ligand‒receptor (L-R) pairs. By performing whole-exome sequencing in 93 patients, mutations enriched in BCR-NFkB and TLR pathways and the cooperation of these two pathways were found to be predominant in PCNS-DLBCL comparing to nonGCB-ecDLBCL. In summary, our study provides comprehensive insights into the transcriptomic and genetic characteristics of PCNS-DLBCL in contrast to ecDLBCL and will help dissect the oncogenic mechanism of this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI